Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICGeneric

NEOMYCIN SULFATE AND DEXAMETHASONE SODIUM PHOSPHATE

DEXAMETHASONE SODIUM PHOSPHATE; NEOMYCIN SULFATE

Standard Dose
EQ 0.1% PHOSPHATE;EQ 3.5MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview NEOMYCIN SULFATE AND DEXAMETHASONE SODIUM PHOSPHATE is listed in Drugs@FDA under application 064055 (ANDA).

Marketing status: Discontinued Active ingredient DEXAMETHASONE SODIUM PHOSPHATE; NEOMYCIN SULFATE Form and strength SOLUTION/DROPS;OPHTHALMIC - EQ 0.1% PHOSPHATE;EQ 3.5MG BASE/ML Sponsor BAUSCH AND LOMB Submission history Latest submission status date: 1995-10-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview NEOMYCIN SULFATE AND DEXAMETHASONE SODIUM PHOSPHATE is listed in Drugs@FDA under application 064055 (ANDA). Marketing status: Discontinued Active ingredient DEXAMETHASONE SODIUM PHOSPHATE; NEOMYCIN SULFATE Form and strength SOLUTION/DROPS;OPHTHALMIC - EQ 0.1% PHOSPHATE;EQ 3.5MG BASE/ML Sponsor BAUSCH AND LOMB Submission history Latest submission status date: 1995-10-30 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.